Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tioclomarol is an anticoagulant of the 4-hydroxycoumarin class and acts as a vitamin K antagonist. It is considered a second-generation drug in this category and is primarily used as a rodenticide to control rodents that are resistant to other anticoagulants of the same class. Tioclomarol functions by inhibiting vitamin K epoxide reductase, thereby blocking the recycling of vitamin K and reducing the synthesis of active clotting factors dependent on vitamin K. This mechanism disrupts blood coagulation processes[1][4][7]. While structurally related to warfarin and other coumarins used in human medicine for preventing thrombosis, its main application is non-medicinal (rodent control)[1][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tioclomarol.